Job Description

Are you passionate about driving market access strategies and ensuring the availability of life-changing therapies to patients? Do you have experience in the pharmaceutical industry and a strong understanding of the current healthcare landscape? If so, we have an exciting opportunity for you to join our team as an Associate Market Access Manager for Obesity and Cardiovascular & Emerging Therapy Areas (CETA). Apply today and be part of our mission to improve patient access to innovative therapies.About the department
This position will be part of the Market Access Public Affairs (MAPA) Department at Novo Nordisk Malaysia. Our team is devoted to improving patient access to our life-changing therapies. We work collaboratively with health economic opinion leaders, reimbursement agencies, medical associations, and primary care organizations to shape opinions and secure reimbursement for our products. Join us in making a difference in the healthcare community. This role will report directly to MAPA Director.Novo Nordisk has been globally recognized as the Best Place to Work, topping the ranks for two consecutive years in 2022 and 2023. It is an exciting time to join Novo Nordisk and be part of a dynamic company in an even more dynamic industry, helping us achieve our aspirations to establish a global presence in the industry.The position
As an Associate Market Access Manager Obesity & CETA, you will manage MAPA related projects as well as you will play a critical role in interpreting clinical and health economic evidence to support local requirements and formulary listing. Your expertise will contribute to the development of superior value propositions, enabling expanded access of our brands to government sectors. If you are adept at developing pricing strategies, mapping key stakeholders, and coordinating project management, this is your opportunity to make a significant impact within our dynamic and forward-thinking organization.Other role expectations are as follows:

• Achieve the vision, strategy, and access plan for the affiliate in Obesity & CETA. The role will also drive the development and implementation of strategic MAPA plans, including formulary listing and health economics analysis.
• Plan and implement strategic stakeholder projects to support MAPA strategic priorities.
• Develop and communicate superior value propositions for expanding access of Novo Nordisk brands in the government sector.
• Prepare submission dossiers for Therapeutic Areas to optimize access to Novo Nordisk products.
• Develop pricing strategies and monitor competitor landscape and market dynamics.

Qualifications

• Relevant academic degree within science, business, or public health, with 2-3 years of proven experience in the pharmaceutical industry.
• Strong English proficiency in both written and spoken communication.
• Good knowledge of the current pharmaceutical, diabetes, and obesity landscape
• Strong business acumen and ability to work cross-functionally.
• Excellent communication skills with flexibility to adapt to local needs and engage with various internal stakeholders, including MAPA directors, commercial directors, product and sales managers, medical teams, and regional/global MAPA managers.

Working at Novo Nordisk
At Novo Nordisk, we don\xe2\x80\x99t wait for change. We drive it. We\xe2\x80\x99re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales \xe2\x80\x93 we\xe2\x80\x99re all working to move the needle on patient care.Contact
Please send your CV online (click on Apply and follow the instructions).Deadline
29 June 2024We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we\xe2\x80\x99re life changing.#LI-AMS1

Novo Nordisk